262 related articles for article (PubMed ID: 28347348)
1. Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series.
Ericson-Lindquist K; Johansson A; Levéen P; Elmberger G; Jönsson G; Staaf J; Brunnström H
Diagn Pathol; 2017 Mar; 12(1):31. PubMed ID: 28347348
[TBL] [Abstract][Full Text] [Related]
2. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
4. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
5. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
6. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Dacic S; Villaruz LC; Abberbock S; Mahaffey A; Incharoen P; Nikiforova MN
Oncotarget; 2016 Dec; 7(50):82943-82952. PubMed ID: 27769042
[TBL] [Abstract][Full Text] [Related]
7. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
[TBL] [Abstract][Full Text] [Related]
8. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ
BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
Moore DA; Balbi K; Ingham A; Arkenau HT; Bennett P
J Clin Pathol; 2018 Nov; 71(11):1001-1006. PubMed ID: 30054375
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and molecular study for synchronous lung adenocarcinoma staging.
Donfrancesco E; Yvorel V; Casteillo F; Stachowicz ML; Patoir A; Tiffet O; Péoc'h M; Forest F
Virchows Arch; 2020 Jun; 476(6):835-842. PubMed ID: 31900636
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y
Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615
[TBL] [Abstract][Full Text] [Related]
12. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
Grellety T; Lucchesi C; Hostein I; Auzanneau C; Khalifa E; Soubeyran I; Italiano A
Eur J Cancer; 2017 Oct; 84():250-256. PubMed ID: 28841542
[TBL] [Abstract][Full Text] [Related]
13. The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer.
Tobin NP; Foukakis T; De Petris L; Bergh J
J Intern Med; 2015 Dec; 278(6):545-70. PubMed ID: 26373821
[TBL] [Abstract][Full Text] [Related]
14. The role of next-generation sequencing in the differential diagnosis of composite neoplasms.
Acosta AM; Al Rasheed MRH; Pins MR; Borgen KR; Panchal D; Rogozinska M; Wiley EL; Behm FG; Mohapatra G
Hum Pathol; 2018 Nov; 81():78-88. PubMed ID: 29958927
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation in synchronous primary adenocarcinomas of the left lung: a case report.
Yu X; Sheng D; Jiang J; Ren M; Jin M; Xu S
Int J Clin Exp Pathol; 2015; 8(7):8579-84. PubMed ID: 26339437
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
18. Genomic heterogeneity of multiple synchronous lung cancer.
Liu Y; Zhang J; Li L; Yin G; Zhang J; Zheng S; Cheung H; Wu N; Lu N; Mao X; Yang L; Zhang J; Zhang L; Seth S; Chen H; Song X; Liu K; Xie Y; Zhou L; Zhao C; Han N; Chen W; Zhang S; Chen L; Cai W; Li L; Shen M; Xu N; Cheng S; Yang H; Lee JJ; Correa A; Fujimoto J; Behrens C; Chow CW; William WN; Heymach JV; Hong WK; Swisher S; Wistuba II; Wang J; Lin D; Liu X; Futreal PA; Gao Y
Nat Commun; 2016 Oct; 7():13200. PubMed ID: 27767028
[TBL] [Abstract][Full Text] [Related]
19. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Jurmeister P; Schöler A; Arnold A; Klauschen F; Lenze D; Hummel M; Schweizer L; Bläker H; Pfitzner BM; Mamlouk S; Sers C; Denkert C; Stichel D; Frost N; Horst D; von Laffert M; Capper D
Mod Pathol; 2019 Jun; 32(6):855-865. PubMed ID: 30723296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]